The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Subbarao, B.
Right arrow Articles by Mosier, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Subbarao, B.
Right arrow Articles by Mosier, D. E.

The Journal of Immunology, Vol 130, Issue 5 2033-2037, Copyright © 1983 by American Association of Immunologists


ARTICLES

Induction of B lymphocyte proliferation by monoclonal anti-Lyb 2 antibody

B Subbarao and DE Mosier

Monoclonal antibody to Lyb 2, a differentiation antigen present on all B cells, has been used to study the role of Lyb 2 molecules in B cell activation. Monoclonal anti-Lyb 2 antibody (m-anti-Lyb 2) transforms resting B cells into blast cells and induces proliferation in these activated B cells. The proliferative response to anti-Lyb 2 is a property of the Lyb 5+ subset of B cells, since the antibody fails to stimulate B cells from mice expressing the CBA/N immune defect. B cells activated by anti-Lyb 2 mature into antibody-secreting cells in the added presence of T cell-replacing factors contained in the supernatants from concanavalin A-activated T cells. Thus, Lyb 2 molecules may participate in the delivery of stimulatory signals during the early phases of B lymphocyte activation.


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
L. Chelvarajan, D. Popa, Y. Liu, T. V. Getchell, A. J. Stromberg, and S. Bondada
Molecular mechanisms underlying anti-inflammatory phenotype of neonatal splenic macrophages
J. Leukoc. Biol., August 1, 2007; 82(2): 403 - 416.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Ogimoto, G. Ichinowatari, N. Watanabe, N. Tada, K. Mizuno, and H. Yakura
Impairment of B cell receptor-mediated Ca2+ influx, activation of mitogen-activated protein kinases and growth inhibition in CD72-deficient BAL-17 cells
Int. Immunol., July 1, 2004; 16(7): 971 - 982.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. Greicius, E. Severinson, N. Beauchemin, B. Obrink, and B. B. Singer
CEACAM1 is a potent regulator of B cell receptor complex-induced activation
J. Leukoc. Biol., July 1, 2003; 74(1): 126 - 134.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H.-J. Wu, C. Venkataraman, S. Estus, C. Dong, R. J. Davis, R. A. Flavell, and S. Bondada
Positive Signaling Through CD72 Induces Mitogen-Activated Protein Kinase Activation and Synergizes with B Cell Receptor Signals to Induce X-Linked Immunodeficiency B Cell Proliferation
J. Immunol., August 1, 2001; 167(3): 1263 - 1273.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. L. Chelvarajan, N. L. Gilbert, and S. Bondada
Neonatal Murine B Lymphocytes Respond to Polysaccharide Antigens in the Presence of IL-1 and IL-6
J. Immunol., October 1, 1998; 161(7): 3315 - 3324.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Lai, N. Alaverdi, L. Maltais, and H. C. Morse III
Mouse Cell Surface Antigens: Nomenclature and Immunophenotyping
J. Immunol., April 15, 1998; 160(8): 3861 - 3868.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Venkataraman, N. Muthusamy, S. Muthukkumar, and S. Bondada
Activation of Lyn, Blk, and Btk But Not Syk in CD72-Stimulated B Lymphocytes
J. Immunol., April 1, 1998; 160(7): 3322 - 3329.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1983 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1983 by The American Association of Immunologists, Inc. All rights reserved.